Spectral AI, Inc. (MDAI)
1.64
+0.05
(+3.14%)
USD |
NASDAQ |
Sep 18, 16:00
1.63
-0.01
(-0.61%)
After-Hours: 20:00
Spectral AI Enterprise Value : 55.06M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 55.06M |
| September 17, 2026 | 53.45M |
| September 16, 2026 | 52.16M |
| September 15, 2026 | 53.45M |
| September 14, 2026 | 54.09M |
| September 11, 2026 | 53.77M |
| September 10, 2026 | 52.48M |
| September 09, 2026 | 53.13M |
| September 08, 2026 | 54.09M |
| September 04, 2026 | 52.81M |
| September 03, 2026 | 52.48M |
| September 02, 2026 | 52.65M |
| September 01, 2026 | 52.16M |
| August 31, 2026 | 52.81M |
| August 28, 2026 | 52.81M |
| August 27, 2026 | 54.74M |
| August 26, 2026 | 54.09M |
| August 25, 2026 | 54.74M |
| August 24, 2026 | 53.77M |
| August 21, 2026 | 53.77M |
| August 20, 2026 | 52.81M |
| August 19, 2026 | 54.42M |
| August 18, 2026 | 54.09M |
| August 17, 2026 | 55.06M |
| August 14, 2026 | 56.35M |
| Date | Value |
|---|---|
| August 13, 2026 | 57.96M |
| August 12, 2026 | 52.81M |
| August 11, 2026 | 57.31M |
| August 10, 2026 | 57.31M |
| August 07, 2026 | 58.60M |
| August 06, 2026 | 55.70M |
| August 05, 2026 | 54.74M |
| August 04, 2026 | 55.38M |
| August 03, 2026 | 54.09M |
| July 31, 2026 | 52.16M |
| July 30, 2026 | 53.13M |
| July 29, 2026 | 50.55M |
| July 28, 2026 | 52.48M |
| July 27, 2026 | 55.06M |
| July 24, 2026 | 55.06M |
| July 23, 2026 | 55.06M |
| July 22, 2026 | 56.02M |
| July 21, 2026 | 56.35M |
| July 20, 2026 | 55.38M |
| July 17, 2026 | 56.02M |
| July 16, 2026 | 55.38M |
| July 15, 2026 | 56.67M |
| July 14, 2026 | 56.02M |
| July 13, 2026 | 56.35M |
| July 10, 2026 | 57.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 2.764M |
| Fractyl Health, Inc. | 108.79M |
| NovelStem International Corp. | 2.190M |
| IGC Pharma, Inc. | 29.92M |
| Omnicell, Inc. | 1.347B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.176M |
| Revenue (Quarterly) | 3.524M |
| Total Expenses (Quarterly) | 7.70M |
| EPS Diluted (Quarterly) | -0.1302 |
| Gross Profit Margin (Quarterly) | 31.58% |
| Profit Margin (Quarterly) | -118.5% |
| Earnings Yield | -21.43% |
| Normalized Earnings Yield | -27.09 |